Norway Cancer Research
Immunotherapy Pioneer & Nordic Cancer Care Excellence
Years Cancer Registry
Since 1951
Nordic Immunotherapy
Regional leader
Cervical Cancer Elimination
On track
Nordic Immunotherapy Leadership
Norway leads the Nordic region in developing novel immunotherapy combinations, particularly for melanoma, lung cancer, and kidney cancer.
Impact:
Pioneering immunotherapy protocols adopted worldwide
70+ Years Cancer Registry Excellence
Norway's Cancer Registry, established in 1951, provides comprehensive long-term data tracking cancer trends and treatment outcomes for decades.
Impact:
Informing global cancer prevention and treatment strategies
Proton Therapy Innovation Center
Norway's proton therapy center delivers ultra-precise radiation treatment, especially for pediatric cancers and tumors near critical organs.
Impact:
Minimizing radiation damage to healthy tissue
Cancer Survivorship Research
Norway pioneered research on long-term cancer survivor quality of life, developing interventions to improve post-treatment outcomes.
Impact:
Improving life after cancer for millions globally
Genetic Cancer Research in Nordic Populations
Norwegian researchers identified genetic variants unique to Nordic populations that influence cancer risk and treatment response.
Impact:
Personalized cancer treatment for Scandinavian patients
Universal Healthcare Cancer Excellence
Norway's universal healthcare system achieves world-class cancer survival rates with equitable access for all citizens.
Impact:
Model for accessible, high-quality cancer care
Cervical Cancer Elimination Program
Norway's comprehensive HPV vaccination and screening program is on track to virtually eliminate cervical cancer by 2030.
Impact:
First-in-world cervical cancer elimination
Environmental Cancer Prevention
Norway studies how Arctic and marine environments affect cancer development, providing insights for coastal and northern populations.
Impact:
Understanding cancer in unique environments
Oslo University Hospital - Norwegian Radium Hospital
Oslo
Norway's premier cancer hospital. Leading research in immunotherapy, proton therapy, and precision oncology. Affiliated with University of Oslo.
Key Specialties:
Cancer Registry of Norway
Oslo
One of the world's oldest cancer registries (1951). Comprehensive cancer surveillance and research infrastructure.
Key Specialties:
Norwegian University of Science and Technology (NTNU)
Trondheim
Leading research in cancer survivorship, quality of life, and patient-centered outcomes.
Key Specialties:
Norway welcomes international patients to cutting-edge clinical trials
Novel Immunotherapy Combinations for Melanoma
Testing new combinations of checkpoint inhibitors and targeted therapies for advanced melanoma patients.
Proton Therapy for Pediatric Brain Tumors
Advanced proton beam therapy for childhood brain tumors minimizing long-term cognitive effects.
Cancer Survivor Wellness Program
Comprehensive wellness program improving quality of life for long-term cancer survivors.
Registry-listed trials for Norway currently tracked in our database, sourced from public trial registries.
